Tocilizumab as Add-On Treatment For Residual Positive, Negative, and Cognitive Symptoms of Schizophrenia
Clinical trial NCT02034474 · COMPLETED
Trial details
- NCT number
- NCT02034474
- Sponsor
- New York State Psychiatric Institute
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-01
- Primary completion
- 2017-02-06
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.